Hyunsu Jung Acquires 7,000 Shares of Hyperion DeFi (NASDAQ:HYPD) Stock

Hyperion DeFi, Inc. (NASDAQ:HYPD) insider Hyunsu Jung bought 7,000 shares of the stock in a transaction on Monday, June 1st. The stock was purchased at an average price of $3.70 per share, with a total value of $25,900.00. Following the completion of the acquisition, the insider directly owned 1,384,676 shares in the company, valued at approximately $5,123,301.20. This trade represents a 0.51% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Hyunsu Jung also recently made the following trade(s):

• On Tuesday, June 2nd, Hyunsu Jung bought 1,000 shares of Hyperion DeFi stock. The stock was purchased at an average price of $3.66 per share, with a total value of $3,660.00.

Hyperion DeFi Price Performance

Shares of HYPD stock opened at $3.61 on Thursday. Hyperion DeFi, Inc. has a twelve month low of $1.89 and a twelve month high of $17.18. The stock has a market capitalization of $54.73 million, a price-to-earnings ratio of -0.36 and a beta of 2.47. The stock has a fifty day simple moving average of $3.66 and a two-hundred day simple moving average of $3.64. The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.12.

Hyperion DeFi (NASDAQ:HYPD) last issued its earnings results on Thursday, March 26th. The company reported ($7.76) earnings per share for the quarter. The business had revenue of $0.50 million during the quarter. On average, analysts predict that Hyperion DeFi, Inc. will post 1.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HYPD has been the subject of several research reports. Zacks Research cut Hyperion DeFi from a “hold” rating to a “strong sell” rating in a report on Monday, March 30th. Cantor Fitzgerald upgraded Hyperion DeFi to a “strong-buy” rating in a research note on Thursday, April 9th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Hyperion DeFi in a research note on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $5.88.

Hedge Funds Weigh In On Hyperion DeFi

A number of large investors have recently added to or reduced their stakes in HYPD. Renaissance Technologies LLC bought a new position in Hyperion DeFi in the fourth quarter worth about $663,000. Jane Street Group LLC bought a new position in Hyperion DeFi in the fourth quarter worth about $493,000. Focus Partners Advisor Solutions LLC bought a new position in Hyperion DeFi in the fourth quarter worth about $221,000. Geode Capital Management LLC bought a new position in Hyperion DeFi in the fourth quarter worth about $214,000. Finally, Investment House LLC bought a new position in Hyperion DeFi in the fourth quarter worth about $166,000. 25.84% of the stock is currently owned by institutional investors.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.